These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 38567803)

  • 21. Management of distal ureter and bladder cuff at the time of nephroureterectomy: surgical techniques and predictors of outcome.
    Attalla K; Patnaik S; Vellos T; Mehrazin R
    Future Oncol; 2019 Jul; 15(20):2385-2393. PubMed ID: 31237445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk factors for intravesical recurrence after nephroureterectomy in patients with upper urinary tract urothelial carcinoma.
    Yamashita R; Watanabe R; Ito I; Shinsaka H; Nakamura M; Matsuzaki M; Niwakawa M
    Int Urol Nephrol; 2017 Mar; 49(3):425-430. PubMed ID: 28078533
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bladder chondrosarcoma plus urothelial carcinoma in recurred transitional cell carcinoma of the upper urinary tract: a case report and literature review.
    Cho MH; Kim SH; Park WS; Joung JY; Seo HK; Chung J; Lee KH
    World J Surg Oncol; 2016 Oct; 14(1):270. PubMed ID: 27765044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of smoking status on bladder tumor recurrence after radical nephroureterectomy for upper tract urothelial carcinoma.
    Hagiwara M; Kikuchi E; Tanaka N; Matsumoto K; Ide H; Miyajima A; Masuda T; Nakamura S; Oya M
    J Urol; 2013 Jun; 189(6):2062-8. PubMed ID: 23328579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preoperative Pyuria Predicts for Intravesical Recurrence in Patients With Urothelial Carcinoma of the Upper Urinary Tract After Radical Nephroureterectomy Without a History of Bladder Cancer.
    Sato G; Yoshida T; Yanishi M; Saito R; Murota T; Kawa G; Kinoshita H; Matsuda T
    Clin Genitourin Cancer; 2020 Apr; 18(2):e167-e173. PubMed ID: 31635939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Effect of Diagnostic Ureterorenoscopy on Intravesical Recurrence in Patients Undergoing Nephroureterectomy for Primary Upper Tract Urinary Carcinoma.
    İzol V; Deger M; Ozden E; Bolat D; Argun B; Baltaci S; Celik O; Akgul HM; Tinay İ; Bayazit Y;
    Urol Int; 2021; 105(3-4):291-297. PubMed ID: 33264798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Significance of the timing of ureteral ligation on prognosis during radical nephroureterectomy for upper urinary tract urothelial cancer.
    Inokuchi J; Kuroiwa K; Nishiyama H; Kojima T; Kakehi Y; Sugimoto M; Takenaka A; Fujimoto K; Yamaguchi R; Habuchi T; Hashine K; Mizusawa J; Eba J; Naito S;
    Int J Urol; 2021 Feb; 28(2):208-214. PubMed ID: 33283389
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes for patients with pT0 disease after radical nephroureterectomy for upper-tract urothelial carcinoma.
    Raman JD; Ng CK; Shariat SF; Margulis V; Montorsi F; Karakiewicz P;
    BJU Int; 2009 Jan; 103(1):3-4. PubMed ID: 18717670
    [No Abstract]   [Full Text] [Related]  

  • 29. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma.
    Rink M; Robinson BD; Green DA; Cha EK; Hansen J; Comploj E; Margulis V; Raman JD; Ng CK; Remzi M; Bensalah K; Kabbani W; Haitel A; Rioux-Leclercq N; Guo CC; Chun FK; Kikuchi E; Kassouf W; Sircar K; Sun M; Sonpavde G; Lotan Y; Pycha A; Karakiewicz PI; Scherr DS; Shariat SF
    J Urol; 2012 Aug; 188(2):398-404. PubMed ID: 22698626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Previous, Simultaneous or Subsequent Bladder Cancer on Prognosis after Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma.
    Kuroiwa K; Inokuchi J; Nishiyama H; Kojima T; Kakehi Y; Sugimoto M; Tanigawa T; Fujimoto H; Gotoh M; Masumori N; Ogawa O; Eto M; Ohyama C; Yokomizo A; Matsuyama H; Ichikawa T; Mizusawa J; Eba J; Naito S;
    J Urol; 2019 Dec; 202(6):1127-1135. PubMed ID: 31251717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endoscopic versus laparoscopic management of noninvasive upper tract urothelial carcinoma: 20-year single center experience.
    Cutress ML; Stewart GD; Tudor EC; Egong EA; Wells-Cole S; Phipps S; Thomas BG; Riddick AC; McNeill SA; Tolley DA
    J Urol; 2013 Jun; 189(6):2054-60. PubMed ID: 23228378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor necrosis predicts poor clinical outcomes in patients with node-negative upper urinary tract urothelial carcinoma.
    Zhang XK; Zhang ZL; Yang P; Cai MY; Hu WM; Yun JP; Zhou FJ; Qian CN; Cao Y
    Jpn J Clin Oncol; 2015 Nov; 45(11):1069-75. PubMed ID: 26355163
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Impact of Upper Tract Urothelial Carcinoma Diagnostic Modality on Intravesical Recurrence after Radical Nephroureterectomy: A Single Institution Series and Updated Meta-analysis. Letter.
    Ghoreifi A; Douglawi A; Djaladat H
    J Urol; 2021 Oct; 206(4):1071. PubMed ID: 34228502
    [No Abstract]   [Full Text] [Related]  

  • 34. The Impact of Upper Tract Urothelial Carcinoma Diagnostic Modality on Intravesical Recurrence after Radical Nephroureterectomy: A Single Institution Series and Updated Meta-analysis. Reply.
    Sharma V; Miest TS; Chamie K; Matin SF; Boorjian SA; Potretzke AM
    J Urol; 2021 Oct; 206(4):1072. PubMed ID: 34228501
    [No Abstract]   [Full Text] [Related]  

  • 35. Re: The Effect of Intravesical Chemotherapy in the Prevention of Intravesical Recurrence after Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Meta-Analysis.
    Chang SS
    J Urol; 2016 Nov; 196(5):1400-1401. PubMed ID: 27751450
    [No Abstract]   [Full Text] [Related]  

  • 36. Significant clinicopathologic prognostic factors for bladder recurrence, progression, and cancer-specific survival after surgery among patients with upper urinary tract urothelial carcinoma.
    Kim SH; Song MK; Joung JY; Chung J; Lee KH; Seo HK
    Investig Clin Urol; 2019 Nov; 60(6):432-442. PubMed ID: 31692890
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Site of metastatic recurrence impacts prognosis in patients with high-grade upper tract urothelial carcinoma.
    Cheaib JG; Claus LE; Patel HD; Kates MR; Matoso A; Hahn NM; Bivalacqua TJ; Hoffman-Censits JH; Pierorazio PM
    Urol Oncol; 2021 Jan; 39(1):74.e9-74.e16. PubMed ID: 33071108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of early ureteral ligation on prevention of intravesical recurrence after radical nephroureterectomy for upper urinary tract urothelial carcinoma: a prospective single-arm multicenter clinical trial.
    Yamashita S; Ito A; Mitsuzuka K; Ioritani N; Ishidoya S; Ikeda Y; Numahata K; Orikasa K; Tochigi T; Soma F; Namima T; Arai Y
    Jpn J Clin Oncol; 2017 Sep; 47(9):870-875. PubMed ID: 28903527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factor analysis of intravesical recurrence after retroperitoneoscopic nephroureterectomy for upper tract urothelial carcinoma.
    Yanagi M; Hamasaki T; Akatsuka J; Endo Y; Takeda H; Kondo Y
    BMC Urol; 2021 Dec; 21(1):167. PubMed ID: 34856960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of contralateral kidney volume on renal function after radical nephroureterectomy: Implications for eligibility for neoadjuvant chemotherapy for upper tract urothelial cancer.
    Song W; Sung HH; Han DH; Jeong BC; Seo SI; Jeon SS; Lee HM; Choi HY; Jeon HG
    Urol Oncol; 2017 Mar; 35(3):114.e1-114.e7. PubMed ID: 27908680
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.